Immunogenicity of the BNT162b2 vaccine in frail or disabled nursing home residents: COVID‐A study

BACKGROUND/OBJECTIVES: The safety and immunogenicity of the BNT162b2 coronavirus disease 2019 (COVID‐19) vaccine in older adults with different frailty and disability profiles have not been well determined. Our objective was to analyze immunogenicity of the BNT162b2 mRNA COVID‐19 vaccine in older ad...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Am Geriatr Soc
Main Authors: Salmerón Ríos, Sergio, Mas Romero, Marta, Cortés Zamora, Elisa Belén, Tabernero Sahuquillo, María Teresa, Romero Rizos, Luis, Sánchez‐Jurado, Pedro Manuel, Sánchez‐Nievas, Ginés, Señalada, José Joaquín Blas, García Nogueras, Inmaculada, Estrella Cazalla, Juan de Dios, Andrés‐Pretel, Fernando, Murillo Romero, Antonio, Lauschke, Volker Martin, Stebbing, Justin, Abizanda, Pedro
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Inc. 2021
Assuntos:
COVID‐19‐Related Content
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8250586/
https://ncbi.nlm.nih.gov/pubmed/33768521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jgs.17153
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares